XML 73 R45.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Organization (Details) - Schedule of Major Subsidiaries Consolidated
12 Months Ended
Dec. 31, 2023
Aptorum Therapeutics Limited (“ATL”) [Member]  
Subsidiary of Limited Liability Company or Limited Partnership [Line Items]  
Incorporation date Jun. 30, 2016
Ownership 100.00%
Place of incorporation Cayman Islands
Principle activities Research and development of life science and biopharmaceutical products
APTUS MANAGEMENT LIMITED [Member]  
Subsidiary of Limited Liability Company or Limited Partnership [Line Items]  
Incorporation date May 16, 2017
Ownership 100.00%
Place of incorporation Hong Kong
Principle activities Provision of management services to its holding company and fellow subsidiaries
Aptorum Medical Limited [Member]  
Subsidiary of Limited Liability Company or Limited Partnership [Line Items]  
Incorporation date Aug. 28, 2017
Ownership 90.00%
Place of incorporation Cayman Islands
Principle activities Provision of medical clinic services
Paths Innovations Limited [Member]  
Subsidiary of Limited Liability Company or Limited Partnership [Line Items]  
Incorporation date Apr. 15, 2019
Ownership 100.00%
Place of incorporation Cayman Islands
Principle activities Investment holding company
Paths Diagnostics Pte. Limited [Member]  
Subsidiary of Limited Liability Company or Limited Partnership [Line Items]  
Incorporation date Jun. 05, 2019
Ownership 75.00%
Place of incorporation Singapore
Principle activities Research and development of life science and biopharmaceutical products
Acticule Life Sciences Limited [Member]  
Subsidiary of Limited Liability Company or Limited Partnership [Line Items]  
Incorporation date Jun. 30, 2017
Ownership 80.00%
Place of incorporation Cayman Islands
Principle activities Research and development of life science and biopharmaceutical products
Claves Life Sciences Limited [Member]  
Subsidiary of Limited Liability Company or Limited Partnership [Line Items]  
Incorporation date Aug. 02, 2017
Ownership 100.00%
Place of incorporation Cayman Islands
Principle activities Research and development of life science and biopharmaceutical products
Nativus Life Sciences Limited [Member]  
Subsidiary of Limited Liability Company or Limited Partnership [Line Items]  
Incorporation date Jul. 07, 2017
Ownership 100.00%
Place of incorporation Cayman Islands
Principle activities Research and development of life science and biopharmaceutical products
Videns Incorporation Limited [Member]  
Subsidiary of Limited Liability Company or Limited Partnership [Line Items]  
Incorporation date Mar. 02, 2017
Ownership 100.00%
Place of incorporation Cayman Islands
Principle activities Research and development of life science and biopharmaceutical products
Mios Pharmaceuticals Limited [Member]  
Subsidiary of Limited Liability Company or Limited Partnership [Line Items]  
Incorporation date Mar. 06, 2018
Ownership 97.93%
Place of incorporation Cayman Islands
Principle activities Research and development of life science and biopharmaceutical products
mTOR (Hong Kong) Limited [Member]  
Subsidiary of Limited Liability Company or Limited Partnership [Line Items]  
Incorporation date Nov. 04, 2016
Ownership 90.00%
Place of incorporation Hong Kong
Principle activities Research and development of life science and biopharmaceutical products
Scipio Life Sciences Limited [Member]  
Subsidiary of Limited Liability Company or Limited Partnership [Line Items]  
Incorporation date Jul. 19, 2017
Ownership 97.93%
Place of incorporation Cayman Islands
Principle activities Research and development of life science and biopharmaceutical products
Signate Life Sciences Limited [Member]  
Subsidiary of Limited Liability Company or Limited Partnership [Line Items]  
Incorporation date Aug. 28, 2017
Ownership 100.00%
Place of incorporation Cayman Islands
Principle activities Research and development of life science and biopharmaceutical products